During the past decade, Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii" #1 sponsor was "Pfizer" with 2 trials, followed by "Akros Pharma Inc." with 1 trials sponsored, "AnaptysBio, Inc." with 1 trials sponsored, "Corbus Pharmaceuticals Inc." with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii" #1 collaborator was "Bioskin GmbH" with 1 trials as a collaborator and "Dermira, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii" are "Atopic Dermatitis" (2 trials), "Dermatitis, Atopic" (2 trials), "Psoriasis" (2 trials), "Skin Diseases" (2 trials) and "Dermatitis" (1 trials). Many other conditions were trialed in "Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii" in a lesser frequency.

Most popular intervention types in "Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii" are "Drug" (7 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "Dupilumab" (1 trials) and "Imsidolimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kliniczny Szpital Wojewodzki nr 1 im. F. Chopina, Klinika Dermatologii, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".